2026-05-07 04:25:52
Brigade Enterprises Ltd announces 1:3 bonus issue
Aptus Value Housing Finance India Ltd declares 2nd interim dividend of Rs. 2.50
Gandhar Oil Refinery India Ltd completes purchase of land
eMudhra Ltd recommends final dividend of Rs. 1.25
Raymond Lifestyle Ltd recommends dividend of Rs. 1Stock Report
Ajanta Pharma Ltd Q4 FY2026 consolidated net profit at Rs. 266.70 crores
Posted On : 2026-05-05 21:28:02( TIMEZONE : IST )
Ajanta Pharma Limited has reported Consolidated financial results for the period ended March 31, 2026.
Financial Results (Q4 FY2026) - QoQ Comparison
The company has reported total income of Rs. 1483.07 crores during the period ended March 31, 2026 as compared to Rs. 1399.81 crores during the period ended December 31, 2025.
The company has posted net profit / (loss) of Rs. 266.70 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 273.77 crores for the period ended December 31, 2025.
The company has reported EPS of Rs. 21.34 for the period ended March 31, 2026 as compared to Rs. 21.91 for the period ended December 31, 2025.
| Financials | Q4 FY2026 | Q3 FY2026 | % Change |
| Total Income | ₹ 1483.07 crs | ₹1399.81 crs |  5.95% |
| Net Profit | ₹266.70 crs | ₹273.77 crs |  -2.58% |
| EPS | ₹21.34 | ₹21.91 | -2.60% |
Financial Results (Q4 FY2026) - YoY Comparison
The company has reported total income of Rs. 1483.07 crores during the period ended March 31, 2026 as compared to Rs.1188.52 crores during the period ended March 31, 2025.
The company has posted net profit / (loss) of Rs.266.70 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.225.26 crores for the period ended March 31, 2025.
The company has reported EPS of Rs.21.34 for the period ended March 31, 2026 as compared to Rs.18 for the period ended March 31, 2025.
| Financials | Q4 FY2026 | Q4 FY2025 | % Change |
| Total Income | ₹ 1483.07 crs | ₹1188.52 crs | 24.78% |
| Net Profit | ₹266.70 crs | ₹225.26 crs | 18.40% |
| EPS | ₹21.34 | ₹18 | 18.56% |
Financial Results (Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.5624.93 crores during the Financial Year ended March 31, 2026 as compared to Rs.4742.60 crores during the Financial Year ended March 31, 2025.
The company has posted net profit / (loss) of Rs.1056 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.920.39 crores for the Financial Year ended March 31, 2025.
The company has reported EPS of Rs.84.51 for the Financial Year ended March 31, 2026 as compared to Rs.73.53 for the Financial Year ended March 31, 2025.
| Financials | Year Ended FY2026 | Year Ended FY2025 | % Change |
| Total Income | ₹5624.93 crs | ₹4742.60 crs | 18.60% |
| Net Profit | ₹1056 crs | ₹920.39 crs | 14.73% |
| EPS | ₹84.51 | ₹73.53 | 14.93% |
Shares of Ajanta Pharma Limited was last trading in BSE at Rs. 2900.90 as compared to the previous close of Rs. 2904.15. The total number of shares traded during the day was 6578 in over 1209 trades.
The stock hit an intraday high of Rs. 2921.90 and intraday low of 2854.20. The net turnover during the day was Rs. 19059189.00.
